These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26968416)

  • 1. Complications Following Radical Nephroureterectomy.
    Raman JD; Jafri SM
    Curr Urol Rep; 2016 May; 17(5):36. PubMed ID: 26968416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
    Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
    BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
    Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
    Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma.
    Lin YK; Deliere A; Lehman K; Harpster LE; Kaag MG; Raman JD
    Can J Urol; 2014 Aug; 21(4):7369-73. PubMed ID: 25171281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
    Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.
    Moschini M; Foerster B; Abufaraj M; Soria F; Seisen T; Roupret M; Colin P; De la Taille A; Peyronnet B; Bensalah K; Herout R; Wirth MP; Novotny V; Chlosta P; Bandini M; Montorsi F; Simone G; Gallucci M; Romeo G; Matsumoto K; Karakiewicz P; Briganti A; Shariat SF
    World J Urol; 2017 Oct; 35(10):1541-1547. PubMed ID: 28247066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
    Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy.
    Raman JD; Lin YK; Shariat SF; Krabbe LM; Margulis V; Arnouk A; Lallas CD; Trabulsi EJ; Drouin SJ; Rouprêt M; Bozzini G; Colin P; Peyronnet B; Bensalah K; Bailey K; Canes D; Klatte T
    BJU Int; 2017 Feb; 119(2):268-275. PubMed ID: 27322735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.
    Youssef RF; Krabbe LM; Shariat SF; Lotan Y; Sagalowsky AI; Raman J; Wood CG; Weizer A; Roscigno M; Montorsi F; Bolenz C; Remzi M; Bensalah K; Kassouf W; Margulis V
    World J Urol; 2015 Dec; 33(12):1965-72. PubMed ID: 25957592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and preoperative predictors for major complications following radical nephroureterectomy.
    Kocher NJ; Canes D; Bensalah K; Roupret M; Lallas C; Margulis V; Shariat S; Colin P; Matin S; Tracy C; Xylinas E; Wagner A; Roumiguie M; Kassouf W; Klatte T; Raman JD
    Transl Androl Urol; 2020 Aug; 9(4):1786-1793. PubMed ID: 32944541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Malnutrition on Radical Nephroureterectomy Morbidity and Mortality: Opportunity for Preoperative Optimization.
    Katz M; Wollin DA; Donin NM; Meeks W; Gulig S; Zhao LC; Wysock JS; Taneja SS; Huang WC; Bjurlin MA
    Clin Genitourin Cancer; 2018 Aug; 16(4):e807-e815. PubMed ID: 29550201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10-year population-based analysis.
    Tinay I; Gelpi-Hammerschmidt F; Leow JJ; Allard CB; Rodriguez D; Wang Y; Chung BI; Chang SL
    BJU Int; 2016 Jun; 117(6):954-60. PubMed ID: 26573216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
    Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
    BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
    Gakis G; Fritsche HM; Hassan F; Kluth L; Miller F; Soave A; Otto W; Schwentner C; Todenhöfer T; Dahlem R; Burger M; Fisch M; Stenzl A; Aziz A; Rink M
    Eur J Cancer; 2014 Oct; 50(15):2583-91. PubMed ID: 25088206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma.
    Rao SR; Correa JJ; Sexton WJ; Pow-Sang JM; Dickinson SI; Lin HY; Spiess PE
    BJU Int; 2012 Dec; 110(11 Pt B):E475-80. PubMed ID: 22564727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.